Revolutionizing the Manufacturing of Orally Disintegrating Tablets
About us
At Ziblets, we are driven by a single mission: to revolutionize the way orally disintegrating tablets are manufactured. Founded by a team of scientists and engineers with deep expertise in pharmaceutical technology, we combine cutting-edge research with practical innovation to make drug delivery safer, faster, and more accessible.
Our vision is simple yet powerful—to improve patient compliance and comfort worldwide by advancing the oral disintegrating tablet technology. From children who struggle with swallowing pills to elderly patients requiring easier medication formats, we believe that medicine should adapt to people, not the other way around.
Why Our Technology Matters
At Ziblets, we are pioneering a new approach to orally disintegrating tablet (ODT) manufacturing that focuses on speed, efficiency, and affordability. Traditional production methods are often slow and resource-intensive, driving up costs and limiting accessibility. Our proprietary process streamlines manufacturing, enabling tablets to be produced significantly faster without compromising quality or safety.
With this breakthrough, we aim to redefine how ODTs are made, delivering medicines that are not only easier to take, but also more accessible to those who need them most.
By accelerating production cycles, we reduce operational costs and pass those savings directly to our partners and patients. Our innovation is built on three pillars:
01
Rapid production
optimized processes that shorten manufacturing timelines.
02
Lower costs
efficiency gains that reduce COGS and make ODTs commercially viable at scale.
03
Greater access
scalable technology that supports widespread adoption across markets.
Meet the Team
-
Paolo Raddani
Executive Director
-
Hans Platteeuw
Chief Development Officer
-
Donald Kalff
Member Of The Board
Learn More about Ziblets!
